PONVNCT06083558
Pain and Nausea After Gallbladder Surgery
An observational study of PONV and Postoperative Pain, run by Umeå University at 1 site in Sweden.
Trial summary
The study is primarily an exploratory study of quality registry data for a swedish national cohort of patients who have undergone gallbladder surgery or ERCP, with the aim of investigating the occurrence of pain and PONV (Postoperative Nausea and Vomiting) after gallbladder surgery. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- PONV, Postoperative Pain, Postoperative Complications
- How many people
- 50,000 participants
- Where
- 1 siteSweden
- Study dates
- 1 Jan 2016to Mar 2028
- How long will I take part?
- 6 Months
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adult patients that had undergone gallbladder surgery in Sweden.
Who may be able to join
- Primary gallstone surgery
- Adult patients (>=18 years)
- Procedure performed between 2016 and 2025
- Surgical procedure registered in the national quality registry Gallriks.
Who cannot join
- If multiple surgeries on the same patient in the study database, subsequent procedures to the first procedure is excluded.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Tomi Myrberg, MD PhD contact
Sweden1 site, 1 recruiting
- Recruiting
Umeå University, Dept of surgical and perioperative sciences
Sundsvall, X, 85357
Jakob Wallden, PhD MD, 0703644392, jakob.wallden@gmail.com
Tomi Myrberg, PhD MD, tomi.myrberg@umu.se
About this study
Official title: Pain and Nausea in the Post-anesthesia Care Unit Following Gallbladder Surgery - a Registry Study Using National Data From Gallriks and the Swedish Perioperative Register (SPOR)
The study is primarily an exploratory study of quality registry data for a swedish national cohort of patients who have undergone gallbladder surgery or ERCP, with the aim of investigating the occurrence of pain and PONV (Postoperative Nausea and Vomiting) after gallbladder surgery. Furthermore, the investigators will explorer if there are factors related to the patient or the surgical procedure that are associated with a higher risk of PONV or pain.
Read the detailed description
The project is a registry study with linked data from the Swedish national registry for gallbladder surgery (Gallriks) and the Swedish Perioperative Register (SPOR).
In SPOR, multiple variables are recorded and the main categories include patient characteristics, process data (e.g., times, operating room, planning, cancellations), surgical data (diagnosis, procedure, anesthesia type, times, deviations), and postoperative data (e.g., pain, nausea, complications, times, postoperative care level). The main variables of interest in this project are postoperative nausea and vomiting (PONV) and pain. In SPOR, it is possible to register whether the patient experienced nausea or vomiting and to assess pain in the immediate postoperative period during the stay at the postoperative recovery unit (PACU). The mean time of stay at PACU after gallbladder surgery in Sweden is 3.5 hours.
Gallriks records data related to gallstone surgery, including preoperative factors (including patient's illness), surgical processes, and postoperative outcomes up to 6 months after surgery.
The investigators have estimated that it is possible to include at least 50% of all gallstone surgeries in Sweden, which corresponds to a range of 7,000-8,000 patients per year.
Both quality registers are housed at the Uppsala Clinical Research Center (UCR), which will perform the data linkage. The data extraction process will start with the surgical cases in Gallriks and match them with SPOR. The database delivered to the research group will contain only pseudonymized personal data, with personal identification numbers and names removed.
The objectives of the study are:
- Describe the risk of early PONV (Postoperative Nausea and Vomiting) and pain during the PACU stay following gallstone surgery.
- Identify factors associated with early PONV and pain.
- Test the hypothesis that total intravenous anesthesia has a lower risk of PONV and pain at the PACU compared to inhalation-based anesthesia.
- Test the hypothesis that the addition of a regional block reduces the risk of PONV and pain during the PACU stay.
- Test the hypothesis that patients who experience PONV and/or pain in the postoperative ward have a higher risk of postoperative complications up to 6 months after surgery.
The primary outcome measures are:
- Risk of PONV in the postoperative ward (number of surgical cases with nausea and/or vomiting) / [total number of surgical cases].
- Median pain score (NRS) in the postoperative ward.
- Risk of severe pain (NRS>=7) [number of surgical cases with NRS>=7] / [total number of surgical cases].
- Percentage of patients with complications, unplanned hospitalizations, or reoperations after 30 days and 6 months.
- Based on the data in SPOR and Gallriks, identify factors associated with the primary outcome measures. Variables hypothesized to be associated include gender, age, illness, preoperative pain, type of anesthesia, type of surgery, and length of hospital stay.
- Specifically examine whether total intravenous anesthesia or regional blockade reduces the risk of PONV/pain and whether PONV/pain increases the risk of postoperative complications.
The data will be described using descriptive methods, and associations will be analyzed through univariate and multivariate analysis.
The study database is planned to include the procedures performed during the years 2016-2025. Databases will be delivered on a yearly basis. Analysis and reports/manuscripts from the study might include parts of the whole study period of 10 years.
- Keywords
- cholecystectomy
- Medical subject headings
- Postoperative Nausea and Vomiting, Pain, Postoperative, Postoperative Complications, Gallbladder Diseases
What is being measured
The primary outcome is the main question the study is designed to answer.
Postoperative nausea and vomiting
Incidence of PONV in the postoperative ward (number of surgical cases with nausea and/or vomiting) / [total number of surgical cases].
Measured: Through the stay at the PACU, an average of 3.5 hours
Postoperative Pain
Median pain score (NRS) in the postoperative ward.
NRS = Numerical Rating Scale 0-10. 0 = No pain and 10 = Worst imaginable pain
Measured: Through the stay at the PACU, an average of 3.5 hours
Severe postoperative pain
Incidence of severe pain (NRS>=7) [number of surgical cases with NRS>=7] / [total number of surgical cases].
NRS = Numerical Rating Scale 0-10. 0 = No pain and 10 = Worst imaginable pain
Measured: Through the stay at the PACU, an average of 3.5 hours
Complications after surgery
Percentage of patients with complications, unplanned hospitalizations, or reoperations after 30 days and 6 months
Measured: up to 6 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Oct 2023
- Study start1 Jan 2016
- Primary completion31 Dec 2027 (estimated)
- Study completionMar 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PONVStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Other
- Enrolment
- 50,000 participants (estimated)
- Target duration
- 6 Months
Sponsor and investigators
- Lead sponsor
- Umeå University
- Sponsor type
- University, hospital or other
- Collaborators
- Karolinska Institutet
- Responsible party
- Sponsor
- Investigators
- Jakob Wallden, MD PhD, Principal investigator, Umeå University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06083558
- Sponsor's protocol ID
- GALLSPOR
- Status last verified
- Oct 2023
- First submitted
- 5 Oct 2023
- Last updated
- 16 Oct 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Oct 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Pain and Nausea in the Post-anesthesia Care Unit Following Gallbladder Surgery - a Registry Study Using National Data From Gallriks and the Swedish Perioperative Register (SPOR)
- ClinicalTrials.gov ID
- NCT06083558
- Acronym / sponsor ID
- GALLSPOR
- Keywords
- cholecystectomy
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 50,000 participants (estimated)
- Lead sponsor
- Umeå UniversityUniversity, hospital or other
- Collaborators
- Karolinska Institutet
- Study start
- 1 Jan 2016 (actual)
- Primary completion
- 31 Dec 2027 (estimated)
- Study completion
- Mar 2028 (estimated)
- First posted
- 16 Oct 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study is primarily an exploratory study of quality registry data for a swedish national cohort of patients who have undergone gallbladder surgery or ERCP, with the aim of investigating the occurrence of pain and PONV (Postoperative Nausea and Vomiting) after gallbladder surgery. Furthermore, the investigators will explorer if there are factors related to the patient or the surgical procedure that are associated with a higher risk of PONV or pain.
Detailed description
The project is a registry study with linked data from the Swedish national registry for gallbladder surgery (Gallriks) and the Swedish Perioperative Register (SPOR).
In SPOR, multiple variables are recorded and the main categories include patient characteristics, process data (e.g., times, operating room, planning, cancellations), surgical data (diagnosis, procedure, anesthesia type, times, deviations), and postoperative data (e.g., pain, nausea, complications, times, postoperative care level). The main variables of interest in this project are postoperative nausea and vomiting (PONV) and pain. In SPOR, it is possible to register whether the patient experienced nausea or vomiting and to assess pain in the immediate postoperative period during the stay at the postoperative recovery unit (PACU). The mean time of stay at PACU after gallbladder surgery in Sweden is 3.5 hours.
Gallriks records data related to gallstone surgery, including preoperative factors (including patient's illness), surgical processes, and postoperative outcomes up to 6 months after surgery.
The investigators have estimated that it is possible to include at least 50% of all gallstone surgeries in Sweden, which corresponds to a range of 7,000-8,000 patients per year.
Both quality registers are housed at the Uppsala Clinical Research Center (UCR), which will perform the data linkage. The data extraction process will start with the surgical cases in Gallriks and match them with SPOR. The database delivered to the research group will contain only pseudonymized personal data, with personal identification numbers and names removed.
The objectives of the study are:
- Describe the risk of early PONV (Postoperative Nausea and Vomiting) and pain during the PACU stay following gallstone surgery.
- Identify factors associated with early PONV and pain.
- Test the hypothesis that total intravenous anesthesia has a lower risk of PONV and pain at the PACU compared to inhalation-based anesthesia.
- Test the hypothesis that the addition of a regional block reduces the risk of PONV and pain during the PACU stay.
- Test the hypothesis that patients who experience PONV and/or pain in the postoperative ward have a higher risk of postoperative complications up to 6 months after surgery.
The primary outcome measures are:
- Risk of PONV in the postoperative ward (number of surgical cases with nausea and/or vomiting) / [total number of surgical cases].
- Median pain score (NRS) in the postoperative ward.
- Risk of severe pain (NRS>=7) [number of surgical cases with NRS>=7] / [total number of surgical cases].
- Percentage of patients with complications, unplanned hospitalizations, or reoperations after 30 days and 6 months.
- Based on the data in SPOR and Gallriks, identify factors associated with the primary outcome measures. Variables hypothesized to be associated include gender, age, illness, preoperative pain, type of anesthesia, type of surgery, and length of hospital stay.
- Specifically examine whether total intravenous anesthesia or regional blockade reduces the risk of PONV/pain and whether PONV/pain increases the risk of postoperative complications.
The data will be described using descriptive methods, and associations will be analyzed through univariate and multivariate analysis.
The study database is planned to include the procedures performed during the years 2016-2025. Databases will be delivered on a yearly basis. Analysis and reports/manuscripts from the study might include parts of the whole study period of 10 years.
Study design
- Observational model
- Cohort
- Time perspective
- Other
- Target follow-up
- 6 Months
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adult patients that had undergone gallbladder surgery in Sweden.
Key inclusion criteria (4 listed)
- Primary gallstone surgery
- Adult patients (>=18 years)
- Procedure performed between 2016 and 2025
- Surgical procedure registered in the national quality registry Gallriks.
Key exclusion criteria (1 listed)
- If multiple surgeries on the same patient in the study database, subsequent procedures to the first procedure is excluded.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Postoperative nausea and vomiting
Time frame: Through the stay at the PACU, an average of 3.5 hours
Incidence of PONV in the postoperative ward (number of surgical cases with nausea and/or vomiting) / [total number of surgical cases].
Postoperative Pain
Time frame: Through the stay at the PACU, an average of 3.5 hours
Median pain score (NRS) in the postoperative ward. NRS = Numerical Rating Scale 0-10. 0 = No pain and 10 = Worst imaginable pain
Severe postoperative pain
Time frame: Through the stay at the PACU, an average of 3.5 hours
Incidence of severe pain (NRS>=7) [number of surgical cases with NRS>=7] / [total number of surgical cases]. NRS = Numerical Rating Scale 0-10. 0 = No pain and 10 = Worst imaginable pain
Complications after surgery
Time frame: up to 6 month
Percentage of patients with complications, unplanned hospitalizations, or reoperations after 30 days and 6 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Oct 2023.
Related trials for PONV
Not yet recruiting
Amisulpride Injection for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgery
PONV
Recruiting
Effect of Preoperative Melatonin on Quality of Recovery After Elective Laparoscopic Cholecystectomy
Laparoscopic Cholecystectomy, Postoperative Quality of Recovery
RecruitingObservational study
Opioid-Free Anesthesia in FESS: A Prospective ERAS Study
Chronic Sinusitis, Postoperative Pain
Active, not recruitingPhase 2
Efficacy of Adding Oral Amisulpride to Dual Prophylaxis for Postoperative Nausea and Vomiting in Patients at High Risk for Nausea and Vomiting Undergoing Gynecological Surgery
Post Operative Nausea and Vomiting (PONV)
Not yet recruiting
Comparison Between Opioid-Free Anaesthesia Versus Opioid Based Anesthesia in Reduction Postoperative Nausea and Vomiting (PONV)After Thoracoscopic Lung Resection.
PONV
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Tomi Myrberg, MD PhD contact
Jakob Wallden, MD PhD principal investigator
Umeå University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of PONV and Postoperative Pain, run by Umeå University at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 16 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Jakob Wallden, MD PhD (+46703644392, jakob.wallden@umu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Postoperative nausea and vomiting (time frame: Through the stay at the PACU, an average of 3.5 hours). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2023; AzTrials last refreshed its copy on 28 Oct 2026.